Gayet JL - Search Results

1

Update on the medical treatment of stable angina.

Gayet JL, Paganelli F, Cohen-Solal A. Gayet JL, et al. Arch Cardiovasc Dis. 2011 Oct;104(10):536-44. doi: 10.1016/j.acvd.2011.08.001. Epub 2011 Oct 12. Arch Cardiovasc Dis. 2011. PMID: 22044707 Free article. Review.

2

What Is the Real IMPACT of an Acronym?

Gayet JL. Gayet JL. JACC Cardiovasc Interv. 2021 Apr 26;14(8):928-929. doi: 10.1016/j.jcin.2021.03.020. JACC Cardiovasc Interv. 2021. PMID: 33888240 Free article. No abstract available.

3

[Compared with atorvastatin at the dose of 10 mg per day rosuvastatin was more effective to reach an LDL goal of < 1.00 g/l in high cardiovascular risk patients (ARIANE study)].

Danchin N, Chadarevian R, Gayet JL, Licour M, Valensi P. Danchin N, et al. Among authors: gayet jl. Ann Cardiol Angeiol (Paris). 2007 Apr;56(2):82-7. doi: 10.1016/j.ancard.2007.01.003. Ann Cardiol Angeiol (Paris). 2007. PMID: 17484092 Clinical Trial. French.

4

Incidence of early adverse events surrounding direct current cardioversion of persistent atrial fibrillation. A cohort study of practices.

Guédon-Moreau L, Gayet JL, Galinier M, Frances Y, Lardoux H, Libersa C; Group of Pharmacology and Therapeutics of French Society of Cardiology. Guédon-Moreau L, et al. Among authors: gayet jl. Therapie. 2007 Jan-Feb;62(1):45-8. doi: 10.2515/therapie:2007009. Epub 2007 Mar 21. Therapie. 2007. PMID: 17374347

5

[Treatment with statins in general medicine: dosage and effectiveness. Results of the observational study STATIMED].

Amouyel P, Lamarque H, Gayet JL. Amouyel P, et al. Among authors: gayet jl. Arch Mal Coeur Vaiss. 2005 Dec;98(12):1206-11. Arch Mal Coeur Vaiss. 2005. PMID: 16435599 Clinical Trial. French.

6

Prognosis of patients with atherothrombotic disease: a prospective survey in a non-hospital setting.

Ferrières J, Cambou JP, Gayet JL, Herrmann MA, Leizorovicz A. Ferrières J, et al. Among authors: gayet jl. Int J Cardiol. 2006 Oct 10;112(3):302-7. doi: 10.1016/j.ijcard.2005.09.024. Epub 2005 Dec 1. Int J Cardiol. 2006. PMID: 16325285

7

In response to: K. Vijayalakshmi, et al, vol. 16, no. 12, pp. 707-711: A prospective, randomized trial to determine the early and late reactions after the use of iopamidol 340 (Niopam) and iobitridol 350 (Xenetix) in cardiac catheterization.

Gayet JL, Lefevre T. Gayet JL, et al. J Invasive Cardiol. 2005 Feb;17(2):124. J Invasive Cardiol. 2005. PMID: 15770763 No abstract available.

8

[Aspects of acute renal failure during cardiovascular investigations and procedures which require the administration of iodine contrast medium. Literature review].

Gayet JL. Gayet JL. Arch Mal Coeur Vaiss. 2004 Dec;97(12):1221-30. Arch Mal Coeur Vaiss. 2004. PMID: 15669364 Review. French.

9

[Pharmacologic characteristics of rosuvastatin, a new HMG-CoA reductase inhibitor].

Bousquet P, Gayet JL. Bousquet P, et al. Among authors: gayet jl. Therapie. 2003 Mar-Apr;58(2):113-21. doi: 10.2515/therapie:2003016. Therapie. 2003. PMID: 12942850 Review. French.

10

The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial.

Gayet JL; SCOPE Study Group. Gayet JL, et al. J Hypertens. 2003 Sep;21(9):1771; author reply 1771-2. doi: 10.1097/00004872-200309000-00028. J Hypertens. 2003. PMID: 12923411 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

38 results

Search Page

Filters